Micardis Related Clinical Trials
Telmisartan80mg/hydrochlothiazide12.5mg (Micardis Plus) ABPM Study in China [Completed]
INNOVATION Study - Telmisartan (Micardis?) in Incipient Diabetic Nephropathy [Completed]
Telmisartan80/HCTZ25 Versus telmisartan80/HCTZ12.5 in Hypertension Not Responding to telmisartan80/HCTZ12.5 [Completed]
Trial of Telmisartan 80mg/HCTZ 12.5mg and Telmisartan 40mg/HCTZ 12.5mg in Patients With Hypertension [Completed]
Non-Responder Study to Telmisartan 40mg [Completed]
Telmisartan vs. Valsartan Missed Dose [Completed]
PROBE Parallel 6-wk Treatment Comparing Telmisartan/HCT (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using ABPM [Completed]
PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN [Completed]
A Prospective, Randomised, Double-Blind, Double-Dummy, Forced-Titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study) [Completed]
PRISMA = Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM [Completed]
The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-Diabetic, Normotensive Subjects [Completed]
Combination of Telmisartan 80mg Plus Hydrochlothiazide 12.5mg to Telmisartan 80mg in Patients Failed in Telmisartan 80mg [Completed]
Telmisartan in Haemodialysis Patients With Chronic Heart Failure [Completed]
PRO-POWER: Hypertension With Risk Factors for a Duration of 24 Weeks With Micardis 80mg/Micardis Plus 80mg/12.5mg [Recruiting]
A Randomized, Double-Blind, Parallel-Group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension [Completed]
A Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Phase IV Study Comparing Telmisartan 80 mg + Hydrochlorothiazide 25 mg [Micardis HCT] Versus Valsartan 160 mg + Hydrochlorothiazide 25 mg [Diovan HCT] Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension. [Completed]
Compliance With Antihypertensive Telmisartan Therapy [Not yet recruiting]
A Randomized, Double-Blind, Placebo Controlled Comparison of Telmisartan HCT and Valsartan HCT in HTN Stage I/II Patient [Completed]
The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension [Recruiting]
Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension [Completed]
Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of Hypertension [Completed]
A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients [Recruiting]
Compliance With Antihypertensive Telmisartan Therapy [Recruiting]
The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension [No longer recruiting]
Investigating the Effect of Micardis® on the Average 24h Blood Pressure of Therapy-naive and Therapy-experienced Patients [Recruiting]
Therapy of Essential Hypertension With Kinzal®/ Kinzalplus® [Recruiting]
Treatment of Insulin Resistance in Hypertensive, Obese Adolescents [Recruiting]
Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial [Active, not recruiting]
Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma Activities [Completed]
Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients [Recruiting]
1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy [Completed]
Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension [Recruiting]
Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive Patients [Not yet recruiting]
Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension [Recruiting]
3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension [Completed]
26-Week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension [Recruiting]
Filtered Trial for Telmisartan 40mg Non-Responder [Recruiting]
Telmisartan and Losartan in Hypertensive IGT [Completed]
HALT Progression of Polycystic Kidney Disease (HALT PKD) [Recruiting]
An Open-Label, Long-Term Study of Telmisartan Plus Amlodipine Fixed-Dose Combination [Recruiting]
Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia [Recruiting]
Telmisartan Tab Hypertension [Recruiting]
Regulation of Inflammatory Parameters by Telmisartan in Hypertensive Patients [Recruiting]
Study Evaluating the Efficacy of Nifedipine GITS - Telmisartan Combination in Blood Pressure Control. [Recruiting]
Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia [Completed]
Comparison of Effects of Telmisartan and Valsartan on Neointima Volume in Diabetes [Recruiting]
Telmisartan and Renal Perfusion in Patients With Metabolic Syndrome [Recruiting]
Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment Withdrawal [Recruiting]
Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels [Not yet recruiting]
Open Label Study Telmisartan and Amlodipine in Hypertension [Recruiting]
Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine [Recruiting]
Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes [Terminated]
Telmisartan and Amlodipine Fixed Dose Combination Trial for the Treatment of Severe Hypertension [Recruiting]
A Prospective, Randomized, Double-Blind, Double-Dummy, Forced Titration, Parallel Group Comparison, Multicenter Trial to Compare the Effects of Either Telmisartan (40-80 mg p.o. Once Daily) or Ramipril (5-10 mg p.o. Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 di [Completed]
Evaluation of the Effect of Telmisartan (Micardis® 80 mg/ MicardisPlus® 80/12.5 mg) on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive Patients [Not yet recruiting]
A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension. (ATHOS Study) [Completed]
SMOOTH - Blood Pressure Control in Diabetic/Obese Patients [Completed]
Telmisartan Versus Ramipril After Acute Coronary Syndrome [Recruiting]
Effectiveness of Candesartan and Telmisartan on Morning Hypertension in Japanese Obese Patients [Recruiting]
SAFE-CRP: Structural Alterations and Function of Endothelium in Cardiovascular Risk Patients
DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril [Completed]
T+H25 First Line in Morderate or Severe HTN [Recruiting]
Open-Label Follow-up Trial of Fixed Dose Combination of Telmisartan 80 mg + Hydrochlorothiazide 25 mg [Completed]
Inflammation and Coronary Artery Disease. Role of AT1-Receptor Antagonism [Completed]
Nice Morning- Safety and Efficacy Observational Study of Telmisartan in Hypertensive Patients in Multicenters [Recruiting]
Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS Study [Active, not recruiting]
Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study [Recruiting]
Filtered Trial for Amlodipine Non-Responder [Recruiting]
Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Cardiovascular Risk Assessment [Recruiting]
Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy [Active, not recruiting]
Nt-proBNP Guided Prevention of Cardiovascular Events in a Population of Diabetic Patients Without a History of Cardiac Disease [Recruiting]
Telmisartan+HCTZ, Hypertension [Recruiting]
Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy [Completed]
|
